Is NCT06870136 recruiting in Los Angeles, CA?

Yes, NCT06870136 is currently recruiting participants at its Los Angeles, CA location. This cognitive decline clinical trial is actively enrolling qualified participants.

How do I join the cognitive decline clinical trial in Los Angeles?

To join this clinical trial in Los Angeles, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Los Angeles clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Cognitive Decline Clinical Trial in Los Angeles, CA

About This Cognitive Decline Study in Los Angeles

The rationale for this study is to observe differences in cognitive health outcomes such as short term memory and simple reaction time between a consumer-grade and commercially available Lion's mane mushroom product and a placebo control group. Additionally, the study aims to evaluate the impact of the product on cognitive function, mood, focus, motivation, sleep quality, and stress. A consumer-driven, decentralized observational clinical research study is therefore well-suited for evaluating the impact of this product in this population. The study will evaluate cognitive health outcomes in a broad age-range of adults who have chosen to try this product. The study will incorporate memory and cognitive function tests, participant reported outcome questionnaires and surveys. There is no "doctor-patient" relationship as part of this research since the participant as a consumer is making the informed choice to take the product and participate in the observational process with self-reported measures that can be done at home. Findings from this study will contribute knowledge toward the functional mushrooms and cognitive health and the design of future studies.

Sponsor: M2 Ingredients

Who Can Participate

Inclusion Criteria

Individuals 40-75 years old, inclusive

Has self-reported concerns with reduced memory, focus and cognitive decline

Cognitive Failures Questionnaire score of mild to moderate at screening

Interested in understanding more about their cognitive health and have chosen have chosen to use the study product

Willing to do a 4-week washout from any supplements for memory or cognitive function prior to randomization

Willing to do a 4-week washout prior to randomization from supplements with mushroom compounds or consuming mushrooms known to impact NGF. This includes but may not be limited to: Reishi (ganoderma lucidum), cordyceps (cordyceps militaris or cordyceps sinensis), Lion's mane or Coral Tooth Fungus (hericium coralloides), turkey tail (trametes versicolor), Chage (inonotus obliquus), Maitake (grifola frondosa).

If taking prescription medications for sleep (e.g. Benzodiazepines, zolpidem, zaleplon), or other class of medication for sleep, must be on a "stable dose" for at least 4 weeks prior to enrollment. "Stable dose" is defined as no changes in dosage or frequency of the specified medications for at least 4 weeks prior to enrollment and throughout the study period.

If regularly consuming alcohol, must be willing to stay on a stable amount throughout the study period and to log alcohol consumption.

In good general health at the time of screening (Investigator discretion).

Able to read and understand English.

Able to read, understand, and provide informed consent.

Able to use a personal smartphone device and laptop, download Chloe by People Science and use the BrainHQ web-based assessment platform.

Able to receive shipment of the product at an address within the United States.

Able to complete study assessments over the course of up to 9 weeks.

Exclusion Criteria

Any potential participants who:

Do not have a smartphone and/or internet access.

Concomitant Therapies:

Participants taking prescription medication for sleep (e.g. Benzodiazepines, zolpidem, zaleplon) not on a stable dose for at least 4 weeks

Participants receiving Cognitive Behavioral Therapy for Insomnia (CBTi)

Participants receiving any investigational therapies or treatments within 30 days prior to randomization.

Other Illnesses or Conditions: Participants who have the following conditions or comorbidities are excluded:

Diagnosis of Alzheimer's disease or dementia

Diagnosed neurological condition or assessed as having a learning/behavioural or neurodevelopmental difference such as dyslexia or ADHD

Have a visual impairment that cannot be corrected with glasses or contact lenses, including red green color blindness

Deafness or untreated age-related hearing loss

Confirmed diagnoses of the following sleep disorders: Narcolepsy, Restless Leg Syndrome, Circadian Rhythm Disorders

Current or prior history of psychotic disorder

Diagnosed with Alcohol or Substance Abuse Disorder

Currently pregnant, planning to become pregnant at any time during the study, or breastfeeding

Have a significant illness, disease or condition which, in the opinion of the principal investigator, may impact their ability to participate in the trial or impact the trial outcomes

Long Covid including persistent feelings of brain fog

Participants using any nicotine and cannabis-containing products

Known hypersensitivity or previous allergic reaction to Lion's mane or functional mushrooms.

Are unlikely for any reason to be able to comply with the trial or considered unsuited for participation in the study by the Principal Investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06870136) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cognitive Decline Treatment Options in Los Angeles, CA

If you're searching for cognitive decline treatment options in Los Angeles, CA, this clinical trial (NCT06870136) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cognitive decline specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cognitive decline clinical trials near you to find additional studies recruiting in your area.

Cognitive Decline Clinical Trial in Los Angeles, CA

Expert Care in Los Angeles

IRB Approved

No-Cost Care

Apply for This Los Angeles Location

Why Participate?

Simple Process